ProFrac Holding reports Q3 results

Published 1 day ago Negative
ProFrac Holding reports Q3 results
* ProFrac Holding press release [https://seekingalpha.com/pr/20299899-profrac-holding-corp-reports-third-quarter-2025-results] (ACDC [https://seekingalpha.com/symbol/ACDC]): Q3 Revenue of $403.1M (-29.9% Y/Y) misses by $16.19M.
* Net loss was $92 million compared to net loss of $107 million in second quarter 2025
* Adjusted EBITDA was $41 million compared to $79 million in second quarter 2025; 10% of revenue in the third quarter compared to 16% of revenue in second quarter 2025
* Net cash provided by operating activities of $5 million compared to $97 million in second quarter 2025
* Capital expenditures of $38 million compared to $43 million in second quarter 2025
* Free cash flow of $(29) million compared to $54 million in second quarter 2025.
*
OUTLOOK

In the Stimulation Services segment, the Company believes fourth quarter activity levels could continue to improve from third quarter levels on a flattish fleet count. Pricing in the fourth quarter is expected to be lower on average versus the third quarter. The Company expects results to improve sequentially.

In the Proppant Production segment, the Company expects fourth quarter profitability to improve compared to the third quarter. While pricing pressures persist, the Company anticipates enhanced operational efficiency and increased throughput and volumes to drive sequential improvement.

MORE ON PROFRAC HOLDING

* ProFrac slides after pricing $75M stock offering [https://seekingalpha.com/news/4484447-profrac-slides-after-pricing-75m-stock-offering]
* ProFrac launches $75M public offering [https://seekingalpha.com/news/4484310-profrac-launches-75m-public-offering]
* Seeking Alpha’s Quant Rating on ProFrac Holding [https://seekingalpha.com/symbol/ACDC/ratings/quant-ratings]
* Historical earnings data for ProFrac Holding [https://seekingalpha.com/symbol/ACDC/earnings]
* Financial information for ProFrac Holding [https://seekingalpha.com/symbol/ACDC/income-statement]